Copyright Reports & Markets. All rights reserved.

Global Rocuronium Injection Market Research Report 2021

Request for Sample of this report
Buy now

1 Rocuronium Injection Market Overview

  • 1.1 Product Overview and Scope of Rocuronium Injection
  • 1.2 Rocuronium Injection Segment by Type
    • 1.2.1 Global Rocuronium Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 5ml/vial
    • 1.2.3 10ml/vial
  • 1.3 Rocuronium Injection Segment by Application
    • 1.3.1 Rocuronium Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Special Clinic
    • 1.3.4 Recovery Center
  • 1.4 Global Rocuronium Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Rocuronium Injection Revenue 2016-2027
    • 1.4.2 Global Rocuronium Injection Sales 2016-2027
    • 1.4.3 Rocuronium Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Rocuronium Injection Market Competition by Manufacturers

  • 2.1 Global Rocuronium Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Rocuronium Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Rocuronium Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Rocuronium Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Rocuronium Injection Market Competitive Situation and Trends
    • 2.5.1 Rocuronium Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Rocuronium Injection Players Market Share by Revenue
    • 2.5.3 Global Rocuronium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Rocuronium Injection Retrospective Market Scenario by Region

  • 3.1 Global Rocuronium Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Rocuronium Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Rocuronium Injection Market Facts & Figures by Country
    • 3.3.1 North America Rocuronium Injection Sales by Country
    • 3.3.2 North America Rocuronium Injection Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Rocuronium Injection Market Facts & Figures by Country
    • 3.4.1 Europe Rocuronium Injection Sales by Country
    • 3.4.2 Europe Rocuronium Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Rocuronium Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Rocuronium Injection Sales by Region
    • 3.5.2 Asia Pacific Rocuronium Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Rocuronium Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Rocuronium Injection Sales by Country
    • 3.6.2 Latin America Rocuronium Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Rocuronium Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Rocuronium Injection Sales by Country
    • 3.7.2 Middle East and Africa Rocuronium Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Rocuronium Injection Historic Market Analysis by Type

  • 4.1 Global Rocuronium Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Rocuronium Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Rocuronium Injection Price by Type (2016-2021)

5 Global Rocuronium Injection Historic Market Analysis by Application

  • 5.1 Global Rocuronium Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Rocuronium Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Rocuronium Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Athenex
    • 6.1.1 Athenex Corporation Information
    • 6.1.2 Athenex Description and Business Overview
    • 6.1.3 Athenex Rocuronium Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Athenex Product Portfolio
    • 6.1.5 Athenex Recent Developments/Updates
  • 6.2 AuroMedics
    • 6.2.1 AuroMedics Corporation Information
    • 6.2.2 AuroMedics Description and Business Overview
    • 6.2.3 AuroMedics Rocuronium Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 AuroMedics Product Portfolio
    • 6.2.5 AuroMedics Recent Developments/Updates
  • 6.3 Fresenius Kabi
    • 6.3.1 Fresenius Kabi Corporation Information
    • 6.3.2 Fresenius Kabi Description and Business Overview
    • 6.3.3 Fresenius Kabi Rocuronium Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Fresenius Kabi Product Portfolio
    • 6.3.5 Fresenius Kabi Recent Developments/Updates
  • 6.4 Mylan
    • 6.4.1 Mylan Corporation Information
    • 6.4.2 Mylan Description and Business Overview
    • 6.4.3 Mylan Rocuronium Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Mylan Product Portfolio
    • 6.4.5 Mylan Recent Developments/Updates
  • 6.5 Pfizer
    • 6.5.1 Pfizer Corporation Information
    • 6.5.2 Pfizer Description and Business Overview
    • 6.5.3 Pfizer Rocuronium Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Pfizer Product Portfolio
    • 6.5.5 Pfizer Recent Developments/Updates
  • 6.6 Sagent
    • 6.6.1 Sagent Corporation Information
    • 6.6.2 Sagent Description and Business Overview
    • 6.6.3 Sagent Rocuronium Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Sagent Product Portfolio
    • 6.6.5 Sagent Recent Developments/Updates
  • 6.7 Sandoz
    • 6.6.1 Sandoz Corporation Information
    • 6.6.2 Sandoz Description and Business Overview
    • 6.6.3 Sandoz Rocuronium Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sandoz Product Portfolio
    • 6.7.5 Sandoz Recent Developments/Updates
  • 6.8 X-Gen Pharmaceutical
    • 6.8.1 X-Gen Pharmaceutical Corporation Information
    • 6.8.2 X-Gen Pharmaceutical Description and Business Overview
    • 6.8.3 X-Gen Pharmaceutical Rocuronium Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 X-Gen Pharmaceutical Product Portfolio
    • 6.8.5 X-Gen Pharmaceutical Recent Developments/Updates
  • 6.9 Baxter
    • 6.9.1 Baxter Corporation Information
    • 6.9.2 Baxter Description and Business Overview
    • 6.9.3 Baxter Rocuronium Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Baxter Product Portfolio
    • 6.9.5 Baxter Recent Developments/Updates

7 Rocuronium Injection Manufacturing Cost Analysis

  • 7.1 Rocuronium Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Rocuronium Injection
  • 7.4 Rocuronium Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Rocuronium Injection Distributors List
  • 8.3 Rocuronium Injection Customers

9 Rocuronium Injection Market Dynamics

  • 9.1 Rocuronium Injection Industry Trends
  • 9.2 Rocuronium Injection Growth Drivers
  • 9.3 Rocuronium Injection Market Challenges
  • 9.4 Rocuronium Injection Market Restraints

10 Global Market Forecast

  • 10.1 Rocuronium Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Rocuronium Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Rocuronium Injection by Type (2022-2027)
  • 10.2 Rocuronium Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Rocuronium Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Rocuronium Injection by Application (2022-2027)
  • 10.3 Rocuronium Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Rocuronium Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Rocuronium Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    5ml/vial
    10ml/vial

    Segment by Application
    Hospital
    Special Clinic
    Recovery Center

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Athenex
    AuroMedics
    Fresenius Kabi
    Mylan
    Pfizer
    Sagent
    Sandoz
    X-Gen Pharmaceutical
    Baxter

    Buy now